Skip to main content
Figure 2 | BMC Genomics

Figure 2

From: Biclustering reveals breast cancer tumour subgroups with common clinical features and improves prediction of disease recurrence

Figure 2

Clinical information across all biclusters, sorted in ascending order of early relapse proportion. Panel (A) Patients whose disease free survival (DFS) time was less than 2 years are classified into early relapse group (dark blue); Patients whose DFS time was more than 8 years are classified into late relapse group (dark red); and patients whose DFS time was between 2 and 8 years were grouped into the intermediate group (green). The proportion of samples in each group was computed and biclusters are ranked in ascending order of early relapse proportion. For each bicluster, the proportion of samples in each category of (B) Grade, (C) estrogen receptor (ER) status and (D) tumour subtype are presented.

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us